Sie sind auf Seite 1von 55

Prof.Dr.dr.

Jazanul Anwar SpFK

Department of Pharmacology and Therapeutics


Faculty of Medicine,
Universitas Sumatera Utara
OXYTOCIC / UTEROTONIC AGENTS

1. Giving tone to the uterine muscle.

2. An agent that overcomes relaxation of the


muscular wall of the uterus.
OXYTOCIC / UTEROTONIC AGENTS

Direct action on Stimulation of


uterus smooth muscle prostaglandin
synthesis

At terminal stage of pregnancy


( oxytocin receptor in myometrium)

Uterine contraction

Cervix dilatation & stretching of vagina


OXYTOCIC / UTEROTONIC AGENTS

Stimulation

UTERINE CONTRACTION

Induction/augment dysfunctional labor


Control of post partum hemorhage
Incomplete abortion/abortion therapeutic
OXYTOCIC / UTEROTONIC AGENTS

Oxytocin

Derivate of Ergot Alkaloids

Derivate of Prostaglandin
Oxytocin

Oxytocin is a synthetic compound. It is


identical to the natural hormone which is
found in the posterior pituitary. It causes
potent and selective stimulation of
uterine and mammary gland smooth
muscle.
Pitocin, Syntocinon
Pharmacoynamics
Oxytocin stimulates the contraction
of the uterus by increasing
sodium permeability of uterine
myofibrils.
UTEROTONIC (OXYTOCIN)

Pharmacodynamic :
Alters transmembrane ionic currents in
myometrial smooth muscle cells &
myoepithelial cells of mammary alveoli

Uterine contraction &


leads to milk ejection
Uterine contraction

Cervix dilatation &


stretching of vagina

Stimulation of cervix & vagina

oxytocin secretion
OXYTOCIN
(Posterior pituitary hormone)

Pharmacokinetic :
Oxytocin is destroyed in the GI tract and must be
given either IV, IM, SQ, or by nasal spay.
* RoA : i.v & buccal absorption
* Swallowed inactive
* Not bound to plasma protein
* Catabolized by the kidneys & liver
* Circulating t 1/2 : 5 minutes
UTEROTONIC (OXYTOCIN)

Clinical pharmacology :
Therapeutic :
Induce labor
Augment dysfunctional labor for :
1. Conditions requiring early vaginal delivery:
Rh problem, maternal DM, preeclampsia
2. Uterine inertia
3. Incomplete abortion
UTEROTONIC (OXYTOCIN)

Adverse reaction :

* Maternal death hypertensive episodes


* Uterine rupture
* Water intoxication
* Fetal death
* Afibrinogenemia
UTEROTONIC (OXYTOCIN)

Contraindication :
Fetal distress
Prematurity
Abnormal fetal presentation
Cephalo-pelvic disproportion
Other predispositions for uterine rupture
Using sympathomimetic agents
UTEROTONIC (ERGOT ALKALOIDS)

Adrenoceptors
ERGOT ALKALOIDS
Dopamine receptors
5-HT receptors
Produced by
Histamine
Claviceps purpurea
Acetylcholine

Tyramine
UTEROTONIC (ERGOT ALKALOIDS)

PHARMACOKINETICS:
Variably absorbed from g.i.t

Amino acid alkaloids (ergotamine):


oral dose > i.m
Speed of absorption & peak blood
level improved by caffeine
Drug Interactions or
Contraindications:
Avoid using vasoconstrictors with
oxytocin as it can result in
hypertension.
UTEROTONIC (ERGOT ALKALOIDS)

PHARMACOKINETICS:

Amine alkaloids
(ergonovine / ergometrine) :
Also absorbed from rectum,
buccal cavity, aerosol inhaler
After i.m : slow absorption (reliable)
Metabolism : liver
UTEROTONIC (ERGOT ALKALOIDS)

PHARMACODYNAMICS:
STIMULANT EFFECTS ON THE UTERUS:
Combine agonist, 5-HT receptors
Changes dramatically pregnancy
( dominance 1 receptors as
pregn.progresses)
Sensitivity:
uterus aterm > earlier pregn. > non pregn.
UTEROTONIC (ERGOT ALKALOIDS)

PHARMACODYNAMICS:

STIMULANT EFFECTS ON THE UTERUS:

Small doses: rhytmic contr. & relaxation


Higher doses: powerful & prolonged contr.
Ergonovine : more selective uterus
(drug of choice : obstetric application)
UTEROTONIC (ERGOT ALKALOIDS)

CLINICAL APPLICATION:

For control of late uterine bleeding


(Post-partum hemorrhage)

Should never be given before delivery

Given at the time of delivery of placenta


or immediately afterward
if bleeding is significant
Derivate of Ergot Alkaloids
UTEROTONIC (ERGOT ALKALOIDS)

SIDE EFFECTS :

Nausea, vomiting,
Blood Pressure
UTEROTONIC (ERGOT ALKALOIDS)

TOXICITY:
Gastrointestinal disturbancies:
diarrhea, nausea,
vomiting

activation of medullary vomiting center &
gastrointestinal serotonin receptors
prolonged vasospasm
(gangrene amputation)
Therapy: infusion of large doses of
nitroprusid or nitroglycerin
UTEROTONIC (ERGOT ALKALOIDS)

CONTRA INDICATION :

Obstructive vascular disease &


collagen disease
Derivate of Prostaglandin
UTEROTONIC (PGE2 & PGF2)

Contractile effects

Release of calcium ions

the frequency & strength of


uterine contraction
UTEROTONIC (PGE2 & PGF2)

A. ABORTION

PGE2 & PGF2 (i.v )


produced abortion in 80 % of cases rate
PGF2 (intra-amniotic): success rate 100 %

Adverse effects < i.v


Other road of administration :
i.m, intravaginal
UTEROTONIC (PGE2 & PGF2)

B. FACILITATION OF LABOR

PGE2 & PGF2 pass fetoplacental barrier



fetal toxicity uncommon

Oral PGE2 superior than oral oxytocin,


but = oxytocin i.v
UTEROTONIC (PGE2 & PGF2)

B. FACILITATION OF LABOR

PGE2 & PGF2 have no antidiuretic effect



induction labor in woman :
preeclampsia, cardiac & renal disease

Uterine fetal death



prostglandine alone or + oxytocin
TOCOLYTIC AGENTS

Zain-Hamid R & Anwar Y, Faculty of Medicine,


Universitas Sumatera Utara
TOCOLYTIC AGENTS

Suppress

UTERINE CONTRACTION

Inhibition, delaying or halting labor


TOCOLYTIC AGENTS
Magnesium sulphate
(MgSO4)

Adrenergic agents
(terbutaline, ritodrine)

Calcium Channel blockers


(verapamil, nifedipine)

Prostaglandin synthetase inhibitor


(indomethacin)
Magnesium sulphate
(MgSO4)
Magnesium sulphate
(MgSO4)

Acts as a calcium antagonist &


membrane stabilizer
( the force of contraction)

Prophylaxis for preeclampsia


(1st line therapy)
Prevent seizures continued for
12-24 hours after delivery
Magnesium sulphate
(MgSO4)

Route of Administration: oral & i.v


SIDE EFFECTS:
Feeling of extreme warmth, perspiration,
flushing, nausea, vomiting, blurred vision,
lightheadedness, lethargy, nasal stiffness,
constipation, affects the reflexes,
and slow breathing,
chest pain (taking together with other tocolytic)
Magnesium sulphate
(MgSO4)

TOXICITY:
Hypoxia, respiratory depression,
cardiac arrest
CONTRA INDICATION:
Heart block, myocardial infarction,
myasthenia gravis, renal impairment
Adrenergic agents
(terbutaline, ritodrine)
Adrenergic agents
(terbutaline, ritodrine)

Level of cAMP via adenylate cyclase

level of free calcium ions

smooth muscle relaxation


Terbutaline & ritodrine

or stop uterine contraction

Preterm labor
Terbutaline & ritodrine

Route of Administration:
oral & i.v, subcutaneus
controlled infusion pump
(to give continuous low dose of terbutaline)
Terbutaline & ritodrine

SIDE EFFECTS:
Nervousness, restlessness, insomnia
headache, rapid heart rate, nausea,
hyperglycemia, hypokalemia,
and pulmonary edema, shortness of breath,
chest pain
Terbutaline & ritodrine

WARNING:
Cardiac dysrhythmia, cardiac disease,
hypertension or thyrotoxicosis,
shortness of breath, chest pain or
contraction still exist during
administration of terbutaline & ritodrine
Calcium Channel blockers
(verapamil, nifedipine)
Calcium Channel blockers
(verapamil, nifedipine)

Calcium ions

Entering smooth muscle cells

the force of smooth muscle contraction


Zain-Hamid R & Anwar Y, Faculty of Medicine,
Universitas Sumatera Utara
Calcium Channel blockers
(verapamil, nifedipine)

or stop contraction of uterus

Delay labor
(used for occasional uterus irritability)
Zain-Hamid R & Anwar Y, Faculty of Medicine,
Universitas Sumatera Utara
Calcium Channel blockers
(verapamil, nifedipine)

Route of Administration: oral

SIDE EFFECTS:

Facial flushing, headache, nausea,


palpitation, lightheadedness
Zain-Hamid R & Anwar Y, Faculty of Medicine,
Universitas Sumatera Utara
Calcium Channel blockers
(verapamil, nifedipine)

EFFECTS TO THE NEWBORN:

No serious side effects have been note

Zain-Hamid R & Anwar Y, Faculty of Medicine,


Universitas Sumatera Utara
Prostaglandin synthetase inhibitor
(indomethacin)

Zain-Hamid R & Anwar Y, Faculty of Medicine,


Universitas Sumatera Utara
Prostaglandin synthetase inhibitor
(indomethacin)

Synthesis of prostaglandin

the frequency & strength of


uterine contraction
Zain-Hamid R & Anwar Y, Faculty of Medicine,
Universitas Sumatera Utara
Indomethacin

Recommended as a tocolytic
in preterm labor at << 32 weeks
of gestation

Zain-Hamid R & Anwar Y, Faculty of Medicine,


Universitas Sumatera Utara
Indomethacin

Route of Administration: oral, suppository


SIDE EFFECTS:

Abdominal discomfort, nausea,


vomiting, depression & dizziness
Indomethacin

WARNING:
Pregnant woman who has a story of
bleeding disorders, aspirin sensitivity &
kidney problems
Indomethacin

EFFECTS TO THE NEWBORN:

Have serious side effects on the foetus


Contraindications to Tocolysis

Fetus is older than 37 weeks gestation


Fetus weighs more than 2500g
Fetus is in acute distress or has passed (or
has a fatal anomaly)
Dilation is greater than 4 cm
Chorioamnionitis or intrauterine infection is
present
Mother has severe Pregnancy-
induced_hypertension, eclampsia, active
vaginal bleeding, a cardiac disease, or another
condition which indicates that the pregnancy
should not continue. Fetus is older than 37
weeks gestation

Das könnte Ihnen auch gefallen